Adipo Therapeutics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 13

Adipo Therapeutics General Information

Description

Developer of polymer-based nanoparticles designed to transform the treatment of obesity-related diseases. The company's notch-inhibiting nanoparticles are weekly, self-injected directly into subcutaneous white adipose tissue to convert energy-storing white fat into energy-burning brown fat, leading to systemic metabolic changes including increased energy expenditure, decreased body weight, improved insulin sensitivity, and improved fat storage, enabling patients to lose body weight naturally and restoring metabolic balance for people living with diabetes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Indiana Biosciences Research Institute, 16Tech
  • 1210 Waterway Boulevard
  • Indianapolis, IN 46202
  • United States
+1 (434)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Indiana Biosciences Research Institute, 16Tech
  • 1210 Waterway Boulevard
  • Indianapolis, IN 46202
  • United States
+1 (434)

Adipo Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Adipo Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Accelerator/Incubator 23-Mar-2026 Completed Pre-Clinical Trials
11. Later Stage VC (Series A) 12-Feb-2026 Completed Pre-Clinical Trials
10. Later Stage VC 11-Dec-2024 Completed Pre-Clinical Trials
9. Later Stage VC (Series A) Cancelled Pre-Clinical Trials
8. Seed Round 15-Dec-2023 Completed Pre-Clinical Trials
7. Seed Round 27-Sep-2022 Completed Pre-Clinical Trials
6. Grant 07-Sep-2022 Completed Pre-Clinical Trials
5. Accelerator/Incubator 22-Sep-2021 Completed Pre-Clinical Trials
4. Seed Round 31-Aug-2020 $1.25M $1.25M Completed Startup
3. Grant 01-Jan-2018 $198K Completed Startup
To view Adipo Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Adipo Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of polymer-based nanoparticles designed to transform the treatment of obesity-related diseases. The company's
Drug Discovery
Indianapolis, IN
6 As of 2026

Charlottesville, VA
 

Menlo Park, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Adipo Therapeutics Competitors (3)

One of Adipo Therapeutics’s 3 competitors is Rivus Pharmaceuticals, a Venture Capital-Backed company based in Charlottesville, VA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Rivus Pharmaceuticals Venture Capital-Backed Charlottesville, VA
OrsoBio Venture Capital-Backed Menlo Park, CA
Cyta Therapeutics Venture Capital-Backed Lowell, MA
You’re viewing 3 of 3 competitors. Get the full list »

Adipo Therapeutics Patents

Adipo Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025265140-A1 Processes for preparing nanoparticles Pending 21-Jun-2024

Adipo Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Adipo Therapeutics Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Plug and Play Accelerator/Incubator
Angel (individual) Minority
Prasco (United States) Corporation Minority
AJI Capital Venture Capital Minority
Pier 70 Ventures Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

Adipo Therapeutics FAQs

  • When was Adipo Therapeutics founded?

    Adipo Therapeutics was founded in 2016.

  • Where is Adipo Therapeutics headquartered?

    Adipo Therapeutics is headquartered in Indianapolis, IN.

  • What is the size of Adipo Therapeutics?

    Adipo Therapeutics has 6 total employees.

  • What industry is Adipo Therapeutics in?

    Adipo Therapeutics’s primary industry is Drug Discovery.

  • Is Adipo Therapeutics a private or public company?

    Adipo Therapeutics is a Private company.

  • What is Adipo Therapeutics’s current revenue?

    The current revenue for Adipo Therapeutics is .

  • How much funding has Adipo Therapeutics raised over time?

    Adipo Therapeutics has raised $14.8M.

  • Who are Adipo Therapeutics’s investors?

    Plug and Play, , Prasco (United States), AJI Capital, and Pier 70 Ventures are 5 of 13 investors who have invested in Adipo Therapeutics.

  • Who are Adipo Therapeutics’s competitors?

    Rivus Pharmaceuticals, OrsoBio, and Cyta Therapeutics are competitors of Adipo Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process